The prognostic value of high-grade prostate cancer pattern on MRI-targeted biopsies: predictors for downgrading and importance of concomitant systematic biopsies

被引：0
|
作者：
Cécile Manceau
Gaëlle Fromont-Hankard
Jean-Baptiste Beauval
Marine Lesourd
Christophe Almeras
Anne-Sophie Bajeot
Jean-Romain Gautier
Michel Soulié
Guillaume Loison
Ambroise Salin
Christophe Tollon
Bernard Malavaud
Mathieu Roumiguié
Guillaume Ploussard
机构：
[1] La Croix du Sud Hospital,Department of Urology
[2] CHU-IUCT Oncopole,Department of Urology
[3] CHRU Tours,Department of Pathological Anatomy and Cytology
[4] Inserm UMR 1069,undefined
来源：
World Journal of Urology | 2021年 / 39卷
关键词：
Prostate cancer; Radical prostatectomy; Targeted biopsy; MRI; Systematic biopsy; Downgrading;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3315 / 3321
页数：6
相关论文
共 50 条
  • [21] Comparison of systematic, targeted and combined prostate biopsies for the cancer with MRI lesion
    Gander, J.
    Guandalino, M.
    Vedrine, N.
    Charbonnel, C.
    Gayrel, P.
    Ceruti, F.
    Guy, L.
    PROGRES EN UROLOGIE, 2022, 32 (12): : 836 - 842
  • [22] Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?
    Gold, Samuel A.
    Hale, Graham R.
    Bloom, Jonathan B.
    Smith, Clayton P.
    Rayn, Kareem N.
    Valera, Vladimir
    Wood, Bradford J.
    Choyke, Peter L.
    Turkbey, Baris
    Pinto, Peter A.
    WORLD JOURNAL OF UROLOGY, 2019, 37 (02) : 235 - 241
  • [23] Do Concomitant Systematic Biopsies Add to Fusion Targeted Biopsies in the Diagnosis and Management of Clinically Significant Prostate Cancer?
    Thompson, Alice
    Eguru, Venkat
    Moosa, Sohail
    Ng, Yeung
    UROLOGY RESEARCH AND PRACTICE, 2023, 49 (03) : 169 - 177
  • [24] Extent of High-Grade Prostate Cancer in Multiparametric MRI-Targeted Biopsy Enhances Prediction of Pathologic Stage
    Paulson, Nathan
    Vollmer, Robin
    Humphrey, Peter
    Sprenkle, Preston
    Huber, Steffen
    Amirkhiz, Kamyar Ghabili
    Levi, Angelique
    LABORATORY INVESTIGATION, 2019, 99
  • [25] Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?
    Samuel A. Gold
    Graham R. Hale
    Jonathan B. Bloom
    Clayton P. Smith
    Kareem N. Rayn
    Vladimir Valera
    Bradford J. Wood
    Peter L. Choyke
    Baris Turkbey
    Peter A. Pinto
    World Journal of Urology, 2019, 37 : 235 - 241
  • [26] Extent of High-Grade Prostate Cancer in Multiparametric MRI-Targeted Biopsy Enhances Prediction of Pathologic Stage
    Paulson, Nathan
    Vollmer, Robin
    Humphrey, Peter
    Sprenkle, Preston
    Huber, Steffen
    Amirkhiz, Kamyar Ghabili
    Levi, Angelique
    MODERN PATHOLOGY, 2019, 32
  • [27] Cancer Detection Rates of Systematic and Targeted Prostate Biopsies after Biparametric MRI
    Gayet, Maudy C. W.
    Aa, Anouk A. M. A. van der
    Beerlage, Harrie P.
    Schrier, Bart Ph
    Gielens, Maaike
    Heesakkers, Roel
    Jager, Gerrit J.
    Mulders, Peter F. A.
    Wijkstra, Hessel
    PROSTATE CANCER, 2020, 2020
  • [28] Optimizing multiparametric MRI-targeted biopsies and detection of clinically significant prostate cancer: The role of perilesional sampling
    Noujeim, J- P.
    Belahsen, Y.
    Martin, R.
    Lefebvre, Y.
    Lemort, M.
    Deforche, M.
    Sirtaine, N.
    Roumeguere, T.
    Peltier, A.
    Diamand, R.
    EUROPEAN UROLOGY, 2023, 83 : S249 - S250
  • [29] Definition and predictors of upgrading at final pathology in prostate cancer patients undergoing mri-targeted and systematic biopsies: Results from a large, multi-institutional series
    Gandaglia, G.
    Mazzone, E.
    Ploussard, G.
    Marra, G.
    Valerio, M.
    Campi, R.
    Mari, A.
    Minervini, A.
    Serni, S.
    Moschini, M.
    Marquis, A.
    Beauval, J. -B
    Rakauskas, A.
    Sessa, F.
    Van Den Bergh, R. C. N.
    Rahota, R-G
    Soeterik, T.
    Roumiguie, M.
    Afferi, L.
    Zhuang, J.
    Guo, H.
    Mattei, A.
    Gontero, P.
    Montorsi, F.
    Briganti, A.
    EUROPEAN UROLOGY, 2022, 81 : S924 - S925
  • [30] MRI TRUS/FUSION BIOPSIES: IS MRI ACCURATE IN PREDICTING HIGH GRADE PROSTATE CANCER?
    Lombardo, Riccardo
    Cantiani, Andrea
    Esperto, Francesco
    Kastner, Christof
    ANTICANCER RESEARCH, 2013, 33 (05) : 2284 - 2285
12345